Top Clinical Trials companies in Japan by Return on Equity (ROE)
Japan
# |
Name |
Return on Equity (ROE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
23.95%
|
Dec. 31, 2023 | USD 22.49 | -0.83% |
|
Japan |
|
| 2 |
20.02%
|
Dec. 31, 2023 | USD 45.71 | 2.52% |
|
Japan |
|
| 3 |
16.21%
|
March 31, 2024 | USD 11.72 | -4.48% |
|
Japan |
|
| 4 |
13.49%
|
Sept. 30, 2024 | USD 9.11 | -4.98% |
|
Japan |
|
| 5 |
13.12%
|
March 31, 2024 | USD 14.33 | -1.63% |
|
Japan |
|
| 6 |
11.81%
|
March 31, 2024 | USD 11.63 | 0.67% |
|
Japan |
|
| 7 |
11.08%
|
March 31, 2024 | USD 18.45 | 0.04% |
|
Japan |
|
| 8 |
9.80%
|
March 31, 2024 | USD 3.51 | 6.45% |
|
Japan |
|
| 9 |
9.71%
|
Dec. 31, 2023 | USD 13.98 | -5.45% |
|
Japan |
|
| 10 |
9.24%
|
March 31, 2024 | USD 10.06 | -1.25% |
|
Japan |
|
| 11 |
8.70%
|
March 31, 2024 | USD 9.54 | -0.95% |
|
Japan |
|
| 12 |
7.99%
|
Dec. 31, 2023 | USD 12.89 | -3.06% |
|
Japan |
|
| 13 |
6.40%
|
March 31, 2024 | USD 15.30 | -0.34% |
|
Japan |
|
| 14 |
5.63%
|
June 30, 2024 | USD 8.33 | -0.82% |
|
Japan |
|
| 15 |
5.07%
|
March 31, 2024 | USD 24.50 | -0.22% |
|
Japan |
|
| 16 |
4.95%
|
March 31, 2024 | USD 5.69 | -0.47% |
|
Japan |
|
| 17 |
4.11%
|
March 31, 2024 | USD 2.29 | -0.24% |
|
Japan |
|
| 18 |
4.07%
|
March 31, 2024 | USD 9.07 | -0.68% |
|
Japan |
|
| 19 |
1.98%
|
March 31, 2024 | USD 27.32 | -0.70% |
|
Japan |
|
| 20 |
1.47%
|
March 31, 2024 | USD 2.10 | -1.79% |
|
Japan |
|
| 21 |
1.07%
|
March 31, 2024 | USD 9.47 | 0.08% |
|
Japan |
|
| 22 |
-0.38%
|
March 31, 2024 | USD 1.31 | -20.36% |
|
Japan |
|
| 23 |
-5.29%
|
Dec. 31, 2023 | USD 2.63 | -0.70% |
|
Japan |
|
| 24 |
-10.62%
|
June 30, 2024 | USD 1.01 | 1.37% |
|
Japan |
|
| 25 |
-10.77%
|
Dec. 31, 2023 | USD 6.49 | 2.23% |
|
Japan |
|
| 26 |
-22.80%
|
March 31, 2024 | USD 0.92 | -1.38% |
|
Japan |
|
| 27 |
-29.73%
|
Dec. 31, 2023 | USD 1.92 | 0.39% |
|
Japan |
|
| 28 |
-59.31%
|
Dec. 31, 2023 | USD 0.24 | -2.59% |
|
Japan |
|
| 29 |
-94.69%
|
Jan. 31, 2024 | USD 6.33 | 18.59% |
|
Japan |
|
| 30 |
-131.50%
|
Dec. 31, 2023 | USD 3.76 | 2.75% |
|
Japan |
|
| 31 |
-364.22%
|
March 31, 2024 | USD 0.17 | 0.04% |
|
Japan |
Frequently Asked Questions
-
Which Clinical Trials company in Japan has the highest Return on Equity (ROE) ?
The Clinical Trials company in Japan with the highest Return on Equity (ROE) is GNI Group Ltd. (Tokyo Stock Exchange: 2160.T) at 23.95%.
-
Which Clinical Trials company in Japan has the lowest Return on Equity (ROE) ?
The Clinical Trials company in Japan with the lowest Return on Equity (ROE) is OncoTherapy Science, Inc. (Tokyo Stock Exchange: 4564.T) at -364.22%.
-
What are the top 10 Clinical Trials companies in Japan by Return on Equity (ROE) ?
The top 10 Clinical Trials companies in Japan by Return on Equity (ROE) are GNI Group Ltd., Chugai Pharmaceutical Co., Ltd., Shin Nippon Biomedical Laboratories, Ltd., Fuji Pharma Co., Ltd., Shionogi & Co., Ltd., WDB Holdings Co., Ltd., I'rom Group Co., Ltd., JCR Pharmaceuticals Co., Ltd., Kyowa Kirin Co., Ltd. and Qol Holdings Co., Ltd..
-
What are the bottom 10 Clinical Trials companies in Japan by Return on Equity (ROE) ?
The bottom 10 Clinical Trials companies in Japan by Return on Equity (ROE) are OncoTherapy Science, Inc., Oncolys BioPharma Inc., SanBio Company Limited, Solasia Pharma K.K., Carna Biosciences, Inc., NanoCarrier Co., Ltd., Nxera Pharma Co., Ltd., Soiken Holdings Inc., RaQualia Pharma Inc. and ReproCELL Incorporated.
